浅谈无法手术切除肝门胆管恶性狭窄的内镜治疗策略

外科理论与实践››2020,Vol. 25››Issue (06): 512-514.doi:10.16139/j.1007-9610.2020.06.014

浅谈无法手术切除肝门胆管恶性狭窄的内镜治疗策略

夏明星, 胡冰()

海军军医大学附属东方肝胆外科医院消化内科内镜科,上海 200438

收稿日期:2020-09-22出版日期:2020-11-25发布日期:2022-07-20
通讯作者:胡冰 E-mail:drhubing@aliyun.com

Endoscopic treatment strategies for unresectable malignant hilar bile duct stricture

XIA Mingxing, HU Bing()

Received:2020-09-22Online:2020-11-25Published:2022-07-20
Contact:HU Bing E-mail:drhubing@aliyun.com

摘要/Abstract

中图分类号:

R657.46

夏明星, 胡冰. 浅谈无法手术切除肝门胆管恶性狭窄的内镜治疗策略[J]. 外科理论与实践, 2020, 25(06): 512-514.

XIA Mingxing, HU Bing. Endoscopic treatment strategies for unresectable malignant hilar bile duct stricture[J]. Journal of Surgery Concepts & Practice, 2020, 25(06): 512-514.

参考文献19

[1]	Launois B, Reding R, Lebeau G, et al. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers[J]. J Hepatobiliary Pancreat Surg, 2000, 7(2):128-134. doi:10.1007/s005340050166 URL
[2]	Cheng JL, Bruno MJ, Bergman JJ, et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents[J]. Gastrointest Endosc, 2002, 56(1):33-39. pmid:12085032
[3]	Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline-Updated October 2017[J]. Endoscopy, 2018, 50(9):910-930. doi:10.1055/a-0659-9864 URL
[4]	Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and mana-gement[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(9):557-588. doi:10.1038/s41575-020-0310-zpmid:32606456
[5]	Gao F, Bai Y, Ma SR, et al. Systematic review: photodynamic therapy for unresectable cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2010, 17(2):125-131. doi:10.1007/s00534-009-0109-3 URL
[6]	Wiedmann M, Berr F, Schiefke I, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase Ⅱ study[J]. Gastrointest Endosc, 2004, 60(1):68-75. pmid:15229428
[7]	Ortner MA, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study[J]. Gastroenterology, 2003, 125(5):1355-1363. doi:10.1016/j.gastro.2003.07.015 URL
[8]	Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy[J]. Am J Gastroenterol, 2005, 100(11):2426-2430. doi:10.1111/j.1572-0241.2005.00318.x URL
[9]	Yang J, Wang J, Zhou H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial[J]. Endoscopy, 2018, 50(8):751-760. doi:10.1055/s-0043-124870 URL
[10]	Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection[J]. Ann Surg, 2006, 244(2):230-239. pmid:16858185
[11]	Sharaiha RZ, Natov N, Glockenberg KS, et al. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?[J]. Dig Dis Sci, 2014, 59(12):3099-3102. doi:10.1007/s10620-014-3264-6 URL
[12]	Sharaiha RZ, Sethi A, Weaver KR, et al. Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry[J]. Dig Dis Sci, 2015, 60(7):2164-2169. doi:10.1007/s10620-015-3558-3 URL
[13]	Sangchan A, Kongkasame W, Pugkhem A, et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial[J]. Gastrointest Endosc, 2012, 76(1):93-99. doi:10.1016/j.gie.2012.02.048pmid:22595446
[14]	Mukai T, Yasuda I, Nakashima M, et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial[J]. J Hepatobiliary Pancreat Sci, 2013, 20(2):214-222. doi:10.1007/s00534-012-0508-8 URL
[15]	de Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study[J]. Gastrointest Endosc, 2001, 53(6):547-553. pmid:11323577
[16]	Lee TH, Kim TH, Moon JH, et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video)[J]. Gastrointest Endosc, 2017, 86(5):817-827. doi:10.1016/j.gie.2017.04.037 URL
[17]	Xia MX, Cai XB, Pan YL, et al. Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study[J]. Gastrointest Endosc, 2020, 91(5):1117-1128,e9. doi:10.1016/j.gie.2019.12.023 URL
[18]	Xia MX, Wang SP, Wu J, et al. The risk of acute cholangitis after endoscopic stenting for malignant hilar strictures: a large comprehensive study[J]. J Gastroenterol Hepatol, 2020, 35(7):1150-1157. doi:10.1111/jgh.14954 URL
[19]	Miura F, Okamoto K, Takada T, et al. Tokyo guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1):31-40. doi:10.1002/jhbp.509 URL

浅谈无法手术切除肝门胆管恶性狭窄的内镜治疗策略

Endoscopic treatment strategies for unresectable malignant hilar bile duct stricture

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献19

相关文章15

编辑推荐

Metrics

本文评价

[1]	张玲, 邹多武.ERCP在慢性胰腺炎诊治中的作用[J]. 外科理论与实践, 2023, 28(04): 283-287.
[2]	胡贤荣, 杨档档, 吴军, 赵毅, 陈萃, 张婷, 胡冰.经口胆道镜SpyGlass在肝门部不明原因胆管狭窄诊断中的应用[J]. 外科理论与实践, 2023, 28(04): 361-365.
[3]	朱斯维, 尹新民.腹腔镜肝门部胆管癌根治术的现状与思考[J]. 外科理论与实践, 2023, 28(02): 100-103.
[4]	李相成, 陈妍安澜, 李长贤.肝门部胆管癌根治性切除术中的血管重建技术[J]. 外科理论与实践, 2023, 28(02): 104-109.
[5]	刘坤, 郭伟.肝胆管结石的微创治疗严格要求原则与内镜治疗[J]. 外科理论与实践, 2021, 26(02): 111-114.
[6]	李敬东, 朱建交, 张立鑫, 熊永福.肝门部胆管癌腹腔镜手术根治性切除的争议与共识[J]. 外科理论与实践, 2021, 26(02): 115-119.
[7]	李相成, 季顾惟,.肝门部胆管癌的根治性切除[J]. 外科理论与实践, 2017, 22(03): 185-190.
[8]	郭召平, 黄天生, 吴巍, 吴云林,.食管静脉曲张内镜按需长间隔治疗6年不出血1例[J]. 内科理论与实践, 2015, 10(04): 310-311.
[9]	吴云林, 王晓瑜, 吴巍,.门静脉高压出血拔除三腔二囊管后的内镜治疗[J]. 内科理论与实践, 2015, 10(04): 305-309.
[10]	于学涛, 沈杰,.肝门部胆管癌的治疗进展[J]. 外科理论与实践, 2015, 20(02): 176-179.
[11]	王辉, 王坚, 王昊陆,.影响肝门部胆管癌术后生存率的多因素分析[J]. 外科理论与实践, 2014, 19(05): 444-448.
[12]	徐雷鸣,.结肠直肠癌的内镜微创治疗[J]. 外科理论与实践, 2010, 15(04): 346-347.
[13]	龚彪,潘亚敏,沈丽,赵建敏,曹卫星.原发性肝癌切除术后肝内胆漏的内镜治疗(附8例病例分析)[J]. 外科理论与实践, 2003, 8(03): 255-257.
[14]	董家鸿.肝胆管结石的临床病理类型与手术方式的选择[J]. 外科理论与实践, 2003, 8(02): 99-100.
[15]	王翔,范志宁,赵轩东.经内镜国产胆道支架治疗胆道恶性狭窄28例[J]. 外科理论与实践, 2002, 7(01): 61-62.